VALLEY COTTAGE, N.Y., Jan. 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLBNASDAQ:TASE:NASDAQ:XTL) today announced an...
XTLbio Announces Grant of Human Monoclonal Antibody Patent Patent Covers Antibodies Directed Against Hepatitis B Virus Surface Antigen Rehovot...
XTLbio appoints Stockbroker and Financial Adviser Rehovot, 20 January 2004 - The Board of XTL Biopharmaceuticals Ltd ("XTLbio" or the "Company...
XTLbio announces appointment of Non-Executive Director Rehovot, 12 January 2004 - XTL Biopharmaceuticals Ltd. (LSE:XTL) is pleased to announce the...
RNS Number:2908T XTL Biopharmaceuticals Limited 16 December 2003 XTLbio R&D and Business Development Update Rehovot, Israel, 16 December...
XTLbio R&D and Business Development Update Rehovot, Israel, 16 December 2003 - XTL Biopharmaceuticals Ltd (XTLbio) today announces an update on...
XTLbio Highlights Presence at The Liver Meeting HepeX Programs at 54th Annual AASLD include Poster Presentations, Oral Presentation and...
XTLbio announces appointment of Non-Executive Director Rehovot, Israel, 20 October 2003: XTL Biopharmaceuticals Ltd. (LSE:XTL) is pleased to...
NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company XTL Biopharmaceuticals Limited 2) Name of shareholder having a major interest...
XTLbio ACQUIRES BROAD RIGHTS FROM STANFORD UNIVERSITY TO ANTIBODIES DIRECTED AGAINST HEPATITIS C VIRUS (HCV) Exclusive license enhances XTLbio's...
XTL Biopharmaceuticals Ltd Interim Results for the Six Months Ended 30 June 2003 XTL Biopharmaceuticals Ltd (XTLbio) today announces interim...
RNS Number:6169O XTL Biopharmaceuticals Limited 13 August 2003 13 August 2003 XTL Biopharmaceuticals Ltd XTL Biopharmaceuticals...
XTLbio's HepeX-B Receives Orphan Drug Designation from the FDA Rehovot, Israel, 4 August 2003 - XTL Biopharmaceuticals Ltd. (XTLbio) reported...
XTLBIO RECEIVES NOTIFICATION OF REINSTATEMENT OF FUNDING AND $1.2 MILLION GRANT FROM ISRAEL'S OFFICE OF THE CHIEF SCIENTIST Rehovot, Israel, 23...
XTLbio Announces Purchase of 14% Stake by Israel Healthcare Ventures Rehovot, Israel, 17 July 2003 - XTL Biopharmaceuticals Ltd. (XTLbio...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.